Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
I would love nothing more than for you to be right. But honestly, I think if the day of a successful Sprinter comes, it might even be less than a 50% rise. I hope it’s more, but imo it’s the Activ trial, EUA and actual orders as well which will get this to rise. But even then, 2000% is a big call.
If I was SNG, I dont know how I would feel about UK being high up on the order list. Right now the only country publicly backing SNG is the US. Unless behind the scenes things are occurring, the UK have showed no respect towards SNG. Even the press have been very very quiet. Its like SNG doesn't exist.
When the RNS was released last week I said the price may not increase that much. I’ll say the same today with this RNS. Why? This trial was to confirm safety of the drug, which we sort of already knew. The big thing is how effective it actually is. And that will come with phase 3 trials. In short, it may go up a little, but phase 3 results are the real decider here. In short I am long on this company and think there is huge potential, but today’s RNS won’t cause a rapid rise, although it is a firm step in the right direction.
I don't get how we get an RNS like what we received this morning and we are flat. The market is illogical.
Good RNS, but a few weeks back we saw +30% on no news, today is disappointing so far. What will it take to get this really moving? FDA approval? P3 positive data? 66p a share seems very very low.
Definitely a positive RNS, however I agree it could have been better. Anyway this is an important start and hopefully the first of many more updates.
Whatever the SP goes to, it should be a lot higher than what it closed yesterday, but the market doesn’t always react how you expect.
On my 'fun money' account I am 93.6% SNG, 6.4% 4D. If 4D bag before the end of the year its all going into SNG.
In terms of my targets for the price, I hope for £10, could it go higher than that, definitely, I can't see a 9bn rise in market cap like merk and pfizer did in one day though. But SNG is more than just COVID-19, these crazy price targets people are throwing around I actually am starting to think may not be as crazy as I first thought... Let me dream...
Some good points. I only own shares in 2 companies currently, SNG and 4D. Probably 90% SNG. But I think this is very undervalued and by next year will show solid returns. We are an RNS away from considerable movement so I’m holding for now. I think it would be foolish to sell shares this close to expected news. Gla
One thing I don’t get though, with many companies things are “priced in”. When they hit earnings, won’t go up much because it was expected etc. Why is SNG so low, literally it seems non of this is priced in? And it’s only one likely set of results away from a big rise? Why isn’t this being priced in, are we missing something?
Been following it for a while and I’m now all in on SNG on my stocks and shared account. Not crazy money compared to some people im sure. But this seems like the risk reward is too good to ignore. And 1.70’s seems silly to me. Maybe I’m missing something, but I have my fingers crossed and hoping for a good start to 2022.
GLA
I sometimes think the prices people put out here are ridiculous, but I then look at the current market cap, how COVID is going nowhere, and how this drug isn’t a one trick pony.
I am only invest money I can’t afford to loose.
AJ, IIRC, the phase 2 trial had less than 10 people? So no deaths is good. But repeating that on 610 people. Pretty unlikely imo. But if it did then yes, this is going to go crazy.